杭州柯林(688611) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was CNY 31,430,905.16, representing a decrease of 15.70% compared to the same period last year[2]. - Net profit attributable to shareholders was CNY 4,490,859.15, down 65.54% year-on-year[2]. - The net profit after deducting non-recurring gains and losses was CNY 3,896,919.81, a decline of 66.76% compared to the previous year[2]. - Basic and diluted earnings per share were both CNY 0.06, down 63.48% from the same period last year[2]. - Net profit for Q1 2024 was CNY 4,327,043.14, a decrease of 66.8% compared to CNY 13,031,656.66 in Q1 2023[15]. - Operating profit for Q1 2024 was CNY 5,426,182.47, down 63.0% from CNY 14,632,175.46 in Q1 2023[15]. - Sales revenue from goods and services received in cash was CNY 54,416,812.65, a decrease of 37.0% compared to CNY 86,223,041.25 in Q1 2023[18]. Cash Flow and Assets - The net cash flow from operating activities was CNY 7,177,812.51, a significant drop of 78.91% year-on-year[2]. - Cash flow from operating activities generated CNY 7,177,812.51, a significant decline from CNY 34,035,693.02 in the same period last year[18]. - Cash and cash equivalents decreased significantly from RMB 286,140,519.15 on December 31, 2023, to RMB 80,293,448.06 by March 31, 2024, a decline of approximately 72%[10]. - Total cash and cash equivalents at the end of Q1 2024 were CNY 78,655,380.17, down from CNY 118,071,129.06 at the end of Q1 2023[19]. - Accounts receivable decreased from RMB 127,285,357.82 at the end of 2023 to RMB 105,757,614.71, a reduction of about 17%[10]. - Total assets at the end of the reporting period were CNY 911,742,277.83, a decrease of 2.97% from the end of the previous year[3]. - Total assets decreased from RMB 939,603,086.46 at the end of 2023 to RMB 911,742,277.83 by March 31, 2024, a decline of approximately 3%[11]. - Total liabilities decreased from RMB 96,258,326.04 to RMB 64,070,474.27, a reduction of about 33%[12]. - The company's equity attributable to shareholders increased slightly from RMB 843,286,339.17 to RMB 847,777,198.32, an increase of approximately 0.6%[12]. - Inventory increased from RMB 64,419,447.64 to RMB 66,062,448.25, reflecting a growth of about 2.6%[10]. Research and Development - Research and development expenses totaled CNY 12,157,390.44, an increase of 70.73% compared to the previous year[3]. - R&D expenses accounted for 38.68% of total revenue, an increase of 19.58 percentage points year-on-year[3]. - Research and development expenses increased to CNY 12,157,390.44, up 70.8% from CNY 7,120,890.02 in the previous year[15]. Operational Challenges - The company reported a net profit margin decline due to increased operating costs despite a decrease in revenue[14]. - Total operating revenue for Q1 2024 was RMB 31,430,905.16, a decrease of 15.5% compared to RMB 37,284,193.04 in Q1 2023[14]. - Total operating costs increased to RMB 29,284,281.19 in Q1 2024, up from RMB 26,407,280.26 in Q1 2023, representing an increase of 10.7%[14]. - The company incurred a credit impairment loss of CNY 1,649,163.62, compared to CNY 756,632.63 in Q1 2023, indicating increased credit risk[15]. Future Outlook - The company is focusing on enhancing its product development and market expansion strategies in the upcoming quarters[9]. - The weighted average return on net assets was 0.53%, a decrease of 1.06 percentage points year-on-year[3]. - The total number of ordinary shareholders at the end of the reporting period was 2,563[6].